Skip to main content

Expansion Therapeutics

San Diego, United States

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

$6.9M raised
Jan 2023
Venture - Series Unknown

Top Investors

RA Capital ManagementCormorant Asset ManagementKleiner Perkins5AM VenturesAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Expansion Therapeutics

How much funding has Expansion Therapeutics raised?
Expansion Therapeutics has raised $6.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
Who are Expansion Therapeutics's investors?
Expansion Therapeutics's investors include RA Capital Management, Cormorant Asset Management, Kleiner Perkins, 5AM Ventures, Alexandria Venture Investments.
Where is Expansion Therapeutics headquartered?
Expansion Therapeutics is headquartered in San Diego, United States.
What does Expansion Therapeutics do?
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
What stage is Expansion Therapeutics at?
Expansion Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Expansion Therapeutics — Funding & Investors." VCBacked, January 4, 2023, https://www.vcbacked.co/company/expansion-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2023). Expansion Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/expansion-therapeutics
Wikipedia (cite web)
{{cite web |title=Expansion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/expansion-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .